Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-24-000121
Filing Date
2024-10-29
Accepted
2024-10-29 16:05:13
Documents
47
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20240930.htm   iXBRL 10-Q 702531
2 EX-31.1 lfvn_93024xex311.htm EX-31.1 9634
3 EX-31.2 lfvn_93024xex312.htm EX-31.2 9614
4 EX-32.1 lfvn_93024xex321.htm EX-32.1 4941
5 EX-32.2 lfvn_93024xex322.htm EX-32.2 4921
  Complete submission text file 0000849146-24-000121.txt   3964508

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20240930.xsd EX-101.SCH 22939
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20240930_cal.xml EX-101.CAL 58722
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20240930_def.xml EX-101.DEF 76337
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20240930_lab.xml EX-101.LAB 446445
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20240930_pre.xml EX-101.PRE 265502
50 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20240930_htm.xml XML 347879
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

EIN.: 900224471 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 241405678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)